Abstract
Bioprosthetic heart valves are prone to structural valve deterioration (SVD) due to an inflammatory immune response resulting in calcification, stenosis, and ultimately valve failure. The antigenicity of xenografts is thought to underlie the immune response, with galactose-α-1,3-galactose (alpha-gal) the principal antigen of investigation. The objective of this study is to further characterize the role of alpha-gal in SVD and determine whether the addition of alpha-gal cleavage to tissue engineered porcine aortic valve (PAV) leaflets will attenuate the xenoreactive humoral immune response.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
